Sage Therapeutics, Inc. (SAGE)
NASDAQ: SAGE · IEX Real-Time Price · USD
11.60
-0.10 (-0.85%)
May 20, 2024, 1:07 PM EDT - Market open
Sage Therapeutics Market Cap
Sage Therapeutics has a market cap or net worth of $696.31 million as of May 20, 2024. Its market cap has decreased by -77.85% in one year.
Market Cap
696.31M
Enterprise Value
-18.43M
1-Year Change
-77.85%
Ranking
Category
Stock Price
$11.60
Market Cap Chart
Since July 18, 2014, Sage Therapeutics's market cap has decreased from $751.40M to $696.31M, a decrease of -7.33%. That is a compound annual growth rate of -0.77%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 704.10M | -2.59% |
May 16, 2024 | 722.80M | 2.57% |
May 15, 2024 | 704.70M | -2.34% |
May 14, 2024 | 721.60M | -1.43% |
May 13, 2024 | 732.10M | 2.22% |
May 10, 2024 | 716.20M | -3.56% |
May 9, 2024 | 742.60M | -0.42% |
May 8, 2024 | 745.70M | -4.54% |
May 7, 2024 | 781.20M | -2.03% |
May 6, 2024 | 797.40M | -4.95% |
May 3, 2024 | 838.90M | 6.36% |
May 2, 2024 | 788.70M | -1.31% |
May 1, 2024 | 799.20M | -4.73% |
Apr 30, 2024 | 838.90M | -1.70% |
Apr 29, 2024 | 853.40M | 3.58% |
Apr 26, 2024 | 823.90M | 0.81% |
Apr 25, 2024 | 817.30M | -2.88% |
Apr 24, 2024 | 841.50M | 8.11% |
Apr 23, 2024 | 778.40M | 0.46% |
Apr 22, 2024 | 774.80M | -3.30% |
Apr 19, 2024 | 801.20M | 2.26% |
Apr 18, 2024 | 783.50M | 3.71% |
Apr 17, 2024 | 755.50M | -19.58% |
Apr 16, 2024 | 939.50M | 2.03% |
Apr 15, 2024 | 920.80M | -0.78% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Autolus Therapeutics | 743.90M |
National Research | 741.39M |
ALX Oncology Holdings | 737.74M |
Stoke Therapeutics | 725.51M |
Cogent Biosciences | 717.58M |
PACS Group | 697.15M |
Lyell Immunopharma | 692.16M |
The Pennant Group | 691.05M |